A comprehensive view of Novartis AG. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Australia Patent: Novartis Files Application for 'Methyl 2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1h-cyclopenta(b)pyridine-3-carboxylates and methyl 2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro(3,4-b)pyridine-3-carboxylates as cav1.2 a

Australia Patent: Novartis Files Application for 'Crystalline form of LNP023'

Australia: Novartis, The Trustees of the University of Pennsylvania Receive Patent for 'Human mesothelin chimeric antigen receptors and uses thereof'

US Patent Issued to Novartis on Nov. 22 for "Protein kinase C inhibitors and methods of their use" (Massachusetts, Connecticut Inventors)

US Patent Issued to Novartis on Nov. 22 for "Pharmaceutical composition" (Swiss, German Inventors)

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count